<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="./datadict_v2.xsl"?><data_table id="pht002224.v2" study_id="phs000254.v2" participant_set="1" date_created="Thu Oct 11 13:41:17 2012"><variable id="phv00159419.v2"><name>SUBJID</name><description>Subject ID</description><type>integer</type></variable><variable id="phv00159420.v2"><name>CONSENT</name><description>Consent group</description><type>encoded value</type><value code="1">Disease Specific (Cystic Fibrosis; the use of the data from the consent group of University of Washington is limited to genetic research that facilitates discovery of variation related to cystic fibrosis.)</value><value code="2">GRU (General Research Use; the use of the data from the consent group of Universities of North Carolina is limited to the general research use.)</value></variable><variable id="phv00159421.v2"><name>SUBJ_SOURCE</name><description>Source repository where subjects originate</description><type>string</type></variable><variable id="phv00159422.v2"><name>SOURCE_SUBJID</name><description>Subject ID used in the Source Repository</description><type>integer</type></variable><variable id="phv00159423.v2"><name>AFFECTION_STATUS</name><description>Case or control</description><type>encoded value</type><comment>"Cases" are subjects with chronic &lt;i&gt;Pseudomonas aeruginosa&lt;/i&gt; (&lt;i&gt;P.a.&lt;/i&gt;); "Controls" are subjects who never showed &lt;i&gt;P.a.&lt;/i&gt; positive cultures in consecutive quarters, or only late in life.</comment><value code="1">Control</value><value code="2">Case</value><value code="3">NA</value></variable></data_table>
